Tumor vaccine strategies that employ dendritic cells and tumor lysates: experimental and clinical studies.
Mulé
J J
JJ
Department of Surgery and the Tumor Immunology Program of the Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor 48109-0666, USA.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D000951:Antigens, Neoplasm / Q000008:administration & dosage; D019496:Cancer Vaccines / Q000627:therapeutic use*; D002469:Cell Separation; D003713:Dendritic Cells / Q000276:immunology*; D006433:Hemocyanins / Q000008:administration & dosage / Q000276:immunology; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D006433:Hemocyanins; C032808:keyhole-limpet hemocyanin